Overview

Oral Chinese Herbal Medicine Concurrent With Secukinumab for Severe Plaque Psoriasis

Status:
Recruiting
Trial end date:
2021-12-31
Target enrollment:
0
Participant gender:
All
Summary
The aim of this study is to determine whether oral Chinese herbal medicine in combination secukinumab is effective and safe in the treatment of severe psoriasis.
Phase:
Early Phase 1
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Guangdong Provincial Hospital of Traditional Chinese Medicine
Treatments:
Antibodies, Monoclonal
Criteria
Inclusion Criteria:

1. Psoriasis Area and Severity Index (PASI) scoreā‰„10

2. Meet the requirement of using secukinumab; without the history of inflammatory bowel
disease (IBD)

3. Written/signed informed consent

Exclusion Criteria:

1. Unsuitable for the treatment of secukinumab